[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions, Application, Companies

July 2019 | | ID: BAC4BA9927DEN
Renub Research

US$ 1,490.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery, E-mail Delivery (Word)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The surgically removal of a tissue from any human organ to know the presence of a disease especially cancer is called biopsy. This medical procedure is done by surgeons, cardiologist and radiologist. Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025. The main factor that fuel the market growth is minimal invasive surgical procedure which mitigate the complications and side-effects and proliferating the biopsy device. Increasing private funding for cancer research, government expenditure on healthcare across the world, rising technological up-gradation and favorable reimbursement policies will further propel the global biopsy device market in coming future.

As per world cancer report by the end of year 2020 there will be 15 Million new cancer cases. The rising prevalence of cancer disease across the world like breast cancer, lung cancer, prostate cancer etc will drive the market of biopsy devices. These days, people are more health conscious and they are shifting towards minimal invasive technique over conventional technique to ensure complete safety.

Renub Research report titled “Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)” captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.

Biopsy Needle is one of the Significant Segment in Global Biopsy Device Market

In this report, we have done comprehensive analysis of different types of Biopsy Device product. By biopsy device product, the market is categorized into 4 parts; Biopsy Needle, Guidance system segment, Biopsy Guns, Reagents and kits in which Biopsy needle is one of the most significant segment in global biopsy device market.
  • Biopsy Needle segmented into two parts; Fine Aspiration Needles and Core Needle.
  • Guidance system is further categorized into three parts; Ultrasound-guided, Stereotactic-guided and Clinically guided.
  • Ultrasound-guided is the major segment among guidance system, where ultrasound is done to identify the abnormalities and then use needle to take sample of tissues from that particular places and this whole process takes 30 minutes.
Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer’s like Prostate, Breast and Lungs.

Breast Biopsy is the Largest Application of Global Biopsy Device Market

In this report, we have fragmented the global biopsy device market on the basis of application into three parts; Breast Biopsy, Lung Biopsy and Prostate Biopsy. The prevalence of breast cancer and prostate cancer across the world is rising at the rapid pace and demand of minimally invasive surgeries among the people is also rising and hence it will further propel the market growth of global biopsy device. In this report, breast biopsy alone dominated the biopsy device market.

Asia-Pacific will be one of the Fastest Growing Markets for Biopsy Devices Globally

In this report, we have done complete insight on regional analysis of global biopsy device market. We have categorized the market into four regional front; North America, Europe, Asia-Pacific and Rest of the world. Asia-Pacific will be one of the fastest growing markets for biopsy device.

Company Analysis

The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.

All the 8 companies studied in the report have been studied from 4 points
  • Overview
  • Business Strategy
  • Merger & Acquisition
  • Financial Insight
Biopsy Segments Covered in the Report:
  • Biopsy Needles
  • Guidance Systems
  • Biopsy Guns
  • Reagents and kits
  • Others
Regional Market Covered in the Report:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Key Companies Covered in the Report:
  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Hologic, Inc.
1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMERY

4. GLOBAL – BIOPSY DEVICES MARKET

5. MARKET SHARE – GLOBAL BIOPSY DEVICES

5.1 By Product
5.2 By Application
5.3 By Region
5.4 By End-User

6. BY PRODUCT - BIOPSY DEVICES MARKET

6.1 Biopsy Needles
  6.1.1 Fine Aspiration Needles
  6.1.2 Core Needles
6.2 Guidance Systems
  6.2.1 Ultrasound-guided
  6.2.2 Stereotactic-guided
  6.2.3 Clinically-guided
6.3 Biopsy Guns
6.4 Reagents and kits
6.5 Others (Brushes, Curettes and Punches etc)

7. BY APPLICATION - BIOPSY DEVICES MARKET

7.1 Breast Biopsy
7.2 Lung Biopsy
7.3 Prostate Biopsy
7.4 Others

8. BY REGION - BIOPSY DEVICES MARKET

8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of World

9. BY END - USER - BIOPSY DEVICES MARKET

9.1 Diagnostic Center
9.2 Hospitals
9.3 Others
9.4 C. R. Bard, Inc. – Company Analysis
9.5 Overview
9.6 Merger & Acquisition
9.7 Financial Insight

10. BECTON, DICKINSON AND COMPANY – COMPANY ANALYSIS

10.1 Overview
10.2 Key Devlopments
10.3 Merger & Acquisition
10.4 Financial Insight

11. B. BRAUN MELSUNGEN AG – COMPANY ANALYSIS

11.1 Overview
11.2 Key Devlopments
11.3 Merger & Acquisition
11.4 Financial Insight

12. CARDINAL HEALTH, INC. – COMPANY ANALYSIS

12.1 Overview
12.2 Key Devlopments
12.3 Merger & Acquisition
12.4 Financial Insight

13. OLYMPUS CORPORATION – COMPANY ANALYSIS

13.1 Overview
13.2 Key Devlopments
13.3 Merger & Acquisition
13.4 Financial Insight

14. BOSTON SCIENTIFIC CORPORATION – COMPANY ANALYSIS

14.1 Overview
14.2 Key Developments
14.3 Merger & Acquisition
14.4 Financial Insight

15. MEDTRONIC PLC – COMPANY ANALYSIS

15.1 Overview
15.2 Key Devlopments
15.3 Merger & Acquisition
15.4 Financial Insight

16. HOLOGIC, INC. – COMPANY ANALYSIS

16.1 Overview
16.2 Key Developments
16.3 Merger & Acquisition
16.4 Financial Insight

17. GROWTH DRIVERS

17.1 Inadequate Screening Tests for Particular Cancers
17.2 Demand for Minimally-Invasive Biopsy Technique
17.3 Advancement in Biopsy Techniques
  17.3.1 Point A
  17.3.2 Point B
  17.3.3 Point C
  17.3.4 Point D
  17.3.5 Point E

18. CHALLENGES

18.1 Breast Biopsy Reimbursement Bundling
18.2 Biopsy Limitations

LIST OF FIGURES

Figure 4 1: Global – Biopsy Devices Market (Billion US$), 2011 – 2018
Figure 4 2: Forecast for Global – Biopsy Devices Market (Billion US$), 2019 – 2025
Figure 5 1: By Product - Global Biopsy Devices Market Share (%), 2011 – 2018
Figure 5 2: By Product – Forecast for Global Biopsy Devices Market Share (%), 2019 – 2025
Figure 5 3: By Application - Global Biopsy Devices Market Share (%), 2011 – 2018
Figure 5 4: By Application – Forecast for Global Biopsy Devices Market Share (%), 2019 – 2025
Figure 5 5: By Region – Global Biopsy Devices Market Share (%), 2011 – 2018
Figure 5 6: By Region – Forecast for Global Biopsy Devices Market Share (%), 2019 – 2025
Figure 5 7: By End User – Global Biopsy Devices Market Share (%), 2011 – 2018
Figure 5 8: By End User – Forecast for Global Biopsy Devices Market Share (%), 2019 – 2025
Figure 6 1: Biopsy Needles Market (Million US$), 2011 – 2018
Figure 6 2: Forecast for Biopsy Needles Market (Million US$), 2019 – 2025
Figure 6 3: Fine Aspiration Needles Market (Million US$), 2011 – 2018
Figure 6 4: Forecast for Fine Aspiration Needles Market (Million US$), 2019 – 2025
Figure 6 5: Core Needles Market (Million US$), 2011 – 2018
Figure 6 6: Forecast for Core Needles Market (Million US$), 2019 – 2025
Figure 6 7: Guidance Systems Market (Million US$), 2011 – 2018
Figure 6 8: Forecast for Guidance Systems Market (Million US$), 2019 – 2025
Figure 6 9: Ultrasound-guided Market (Million US$), 2011 – 2018
Figure 6 10: Forecast for Ultrasound-guided Market (Million US$), 2019 – 2025
Figure 6 11: Stereotactic-guided Market (Million US$), 2011 – 2018
Figure 6 12: Forecast for Stereotactic-guided Market (Million US$), 2019 – 2025
Figure 6 13: Clinically-guided Market (Million US$), 2011 – 2018
Figure 6 14: Forecast for Clinically-guided Market (Million US$), 2019 – 2025
Figure 6 15: Biopsy Guns Market (Million US$), 2011 – 2018
Figure 6 16: Forecast for Biopsy Guns Market (Million US$), 2019 – 2025
Figure 6 17: Reagents and kits Market (Million US$), 2011 – 2018
Figure 6 18: Forecast for Reagents and kits Market (Million US$), 2019 – 2025
Figure 6 19: Others Biopsy Devices Market (Million US$), 2011 – 2018
Figure 6 20: Forecast for Others Biopsy Devices Market (Million US$), 2019 – 2025
Figure 7 1: Breast Biopsy Devices Market (Million US$), 2011 – 2018
Figure 7 2: Forecast for Breast Biopsy Devices Market (Million US$), 2019 – 2025
Figure 7 3: Lung Biopsy Devices Market (Million US$), 2011 – 2018
Figure 7 4: Forecast for Lung Biopsy Devices Market (Million US$), 2019 – 2025
Figure 7 5: Prostate Biopsy Devices Market (Million US$), 2011 – 2018
Figure 7 6: Forecast for Prostate Biopsy Devices Market (Million US$), 2019 – 2025
Figure 7 7: Others Biopsy Devices Market (Million US$), 2011 – 2018
Figure 7 8: Forecast for Others Biopsy Devices Market (Million US$), 2019 – 2025
Figure 8 1: North America Biopsy Devices Market (Million US$), 2011 – 2018
Figure 8 2: Forecast for North America Biopsy Devices Market (Million US$), 2019 – 2025
Figure 8 3: Europe Biopsy Devices Market (Million US$), 2011 – 2018
Figure 8 4: Forecast for Europe Biopsy Devices Market (Million US$), 2019 – 2025
Figure 8 5: Asia-Pacific Biopsy Devices Market (Million US$), 2011 – 2018
Figure 8 6: Forecast for Asia-Pacific Biopsy Devices Market (Million US$), 2019 – 2025
Figure 8 7: Rest of World Biopsy Devices Market (Million US$), 2011 – 2018
Figure 8 8: Forecast for Rest of World Biopsy Devices Market (Million US$), 2019 – 2025
Figure 9 1: By End User- Forecast for Diagnostic Center Market (Million US$), 2019 – 2025
Figure 9 2: By End User- Hospital Market (Million US$), 2011 – 2018
Figure 9 3: By End User- Forecast for Hospital Market (Million US$), 2019 – 2025
Figure 9 4: By End User- Others Market (Million US$), 2011 – 2018
Figure 9 5: By End User- Forecast for Others Market (Million US$), 2019 – 2025
Figure 9 6: C. R. Bard – Financial Insights (Million US$), 2010 – 2017
Figure 10 1: Becton, Dickinson and Company – Financial Insights (Million US$), 2014 – 2018
Figure 10 2: Becton, Dickinson and Company – Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 11 1: B. Braun Melsungen AG – Financial Insights (Million US$), 2014 – 2018
Figure 11 2: B. Braun Melsungen AG - Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 12 1: Cardinal Health, Inc. – Financial Insights (Million US$), 2014 – 2018
Figure 12 2: Cardinal Health, Inc. – Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 13 1: Olympus Corporation – Financial Insights (Million US$), 2014 – 2018
Figure 13 2: Olympus Corporation – Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 14 1: Boston Scientific Corporation – Financial Insights (Million US$), 2014 – 2018
Figure 14 2: Boston Scientific Corporation – Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 15 1: Medtronic plc – Financial Insights (Million US$), 2014 – 2018
Figure 15 2: Medtronic plc – Financial Insights Forecasted (Million US$), 2019 – 2025
Figure 16 1: Hologic Inc. – Financial Insights (Million US$), 2014 – 2018
Figure 16 2: Hologic Inc. – Financial Insights Forecast (Million US$), 2019 – 2025

LIST OF TABLE

Table 6 1: New Bundled Codes for Breast Biopsy with Image Guidance
Table 6 2: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015


More Publications